Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q35683669)
Watch
English
Chemotherapy for advanced epithelial ovarian cancer
scientific article published on August 1, 1992
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
1500391
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1500391%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 September 2019
review article
1 reference
stated in
Europe PubMed Central
title
Chemotherapy for advanced epithelial ovarian cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
1500391
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1500391%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 September 2019
main subject
chemotherapy
1 reference
based on heuristic
inferred from title
ovarian cancer
1 reference
based on heuristic
inferred from title
author name string
Ozols RF
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
1500391
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1500391%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 September 2019
language of work or name
English
1 reference
stated in
National Center for Biotechnology Information
PubMed publication ID
1500391
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1500391
retrieved
2 October 2022
publication date
1 August 1992
1 reference
stated in
Europe PubMed Central
PubMed publication ID
1500391
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1500391%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 September 2019
published in
Hematology / Oncology Clinics of North America
1 reference
stated in
Europe PubMed Central
PubMed publication ID
1500391
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1500391%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 September 2019
volume
6
1 reference
stated in
Europe PubMed Central
PubMed publication ID
1500391
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1500391%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 September 2019
issue
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
1500391
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1500391%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 September 2019
page(s)
879-894
1 reference
stated in
Europe PubMed Central
PubMed publication ID
1500391
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1500391%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 September 2019
cites work
Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized study of cyclophosphamide and cis-platinum with or without doxorubicin in advanced ovarian carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Carboplatin dosage: prospective evaluation of a simple formula based on renal function
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Carboplatin, doxorubicin, and cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide: a randomized trial in stage III-IV epithelial ovarian carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Second thoughts about second-look laparotomy in advanced ovarian cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compounds
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ovarian cancer, Part I: Biology
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dose intensity analysis of chemotherapy regimens in ovarian carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hexamethylmelamine as a single second-line agent in ovarian cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized trial comparing two combination chemotherapy regimens (CHAP-5 v CP) in advanced ovarian carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Depletion of Glutathione in Normal and Malignant Human Cells In Vivo by Buthionine Sulfoximine: Clinical and Biochemical Results
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cyclophosphamide plus cisplatin versus cyclophosphamide, doxorubicin, and cisplatin chemotherapy of ovarian carcinoma: a meta-analysis. The Ovarian Cancer Meta-Analysis Project
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High-dose carboplatin in refractory ovarian cancer patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High-dose cisplatin in hypertonic saline in refractory ovarian cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Resistance to alkylating agents and cisplatin: insights from ovarian carcinoma model systems
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I and clinical pharmacological evaluation of aphidicolin glycinate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Is routine second-look laparotomy for ovarian cancer justified?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of ifosfamide and mesna in advanced ovarian carcinoma: a Gynecologic Oncology Group Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Carboplatin in combination therapy for ovarian cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930316-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0889-8588(18)30316-2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
1500391
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1500391%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 September 2019
PubMed publication ID
1500391
1 reference
stated in
Europe PubMed Central
PubMed publication ID
1500391
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1500391%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 September 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
